Kyntra Bio, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993, and is headquartered in San Francisco, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
225
Frequently Asked Questions
What is Market Cap of Kyntra Bio Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Kyntra Bio Inc. market cap is $36.69M.
What is the 52-week high for Kyntra Bio Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Kyntra Bio Inc. 52 week high is $21.94 as of January 14, 2026.
What is the 52-week low for Kyntra Bio Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Kyntra Bio Inc. 52 week low is $4.85 as of January 14, 2026.
What is Kyntra Bio Inc. stock price today?
Kyntra Bio Inc. stock price today is $9.13.
What was Kyntra Bio Inc. stock price yesterday?
Kyntra Bio Inc. stock price yesterday was $9.07.
What is the PE ratio of Kyntra Bio Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Kyntra Bio Inc.’s P/E ratio is 0.23.
What is the Price-to-Book ratio of Kyntra Bio Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Kyntra Bio Inc. P/B ratio is -2.1691.
What is the 50-day moving average of Kyntra Bio Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Kyntra Bio Inc. 50-day moving average is $9.10.